News | February 21, 2014

Cardinal Health Showcases RFID Technology at HIMSS14

WaveMark RFID technology added to Cardinal Health Inventory Management Solutions

Cardinal Health WaveMark RFID Inventory Management Cath Lab HIMSS 2014

February 21, 2014 — Cardinal Health will feature newly acquired WaveMark and its radio frequency identification (RFID) technology at the Healthcare Information and Management Systems Society (HIMSS) annual meeting in Orlando, Fla. With the WaveMark RFID technology, the company’s inventory management solution is powered by a SaaS-based analytics platform.

With the integration of WaveMark technologies, the Cardinal Health Inventory Management Solutions (CIMS) enables real-time tracking and management of inventory across the entire supply chain, from manufacturer to point of care. The product visibility and inventory control resulting from the solution’s use can help hospitals, integrated delivery networks, medical device manufacturers and distributors.

The system is compatible with hospital information systems and is in place in hospital systems such as the Veteran’s Health Administration, Emory- St. Joseph’s in Atlanta and Florida Hospital in Orlando, Fla. The software platform leverages RFID, barcode and demand signaling methodologies to enable acute and ambulatory care centers to assemble customized inventory management workflows.

WaveMark technology will now be marketed as a component of Cardinal Health Inventory Management Solutions. Cardinal Health Inventory Management Solutions will be featured in the HIMSS Intelligent Hospital Pavilion, which simulates real-life scenarios within a hospital environment. Pavilion visitors can gain an overview of how technologies are integrated to enhance patient care, optimize workflow and manage resources. 

For more information: www.cardinalhealth.com

Related Content

Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
News | Peripheral Artery Disease (PAD)| September 13, 2017
A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ Detour...
Overlay Init